Zhang et al. [11] previously ascertained that miR-657 was capable to promote malignant activity in HCC cells via targeting transducin-like enhancer protein 1 and modulating associated NF-κB signaling. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.